VC Firm, XVC Tech Enters the AI Healthcare Tech Sector Via Investment in Shealth.AI
Monday,11/11/2024|11:11GMTby
James Clifford
Shealth.AI and XVC, through its partnership, seek to eliminate sector problems.
XVC Tech, one of the leading venture capital (VC) firms committed to exploring potential investment opportunities in technology solutions, is entering the budding healthcare tech sector. Through a strategic investment into Shealth.AI—an Artificial Intelligence (AI) start-up dedicated to improving the healthcare sector—this is the VC firm’s first foray into the billion-dollar AI-based healthcare market.
Shealth.AI is leveraging AI to revolutionize global diagnostics, and since its launch, has become the go-to solution for labs, hospitals, and diagnostic centers. While the financial details of this investment are unknown, at least for now, it aims to harness Shealth.AI’s game-changing features to revamp the existing healthcare industry.
The current healthcare tech sector is problem-laden. The dearth of accurate clinical research, operating costs, regulatory issues, and privacy concerns are a few of the major sticking points in this industry. Shealth.AI and XVC, through this partnership, seek to eliminate them.
Eliminating Existing Industry Challenges
According to several studies and a disease incidence data report from 2012 to 2014, an estimated 594,000 patients die or are temporarily/ permanently disabled due to inaccurate diagnosis. Shealth.AI is positioned to eliminate this major problem. The leading healthcare tech solution leverages AI to guarantee quick yet nearly 99% accurate diagnostics in imaging-based assessments. This enhances clinical efficiency on a greater scale as well as improves patient care outcomes.
Shealth.AI’s dedication to privacy is another standout feature and a crucial driver behind XVC Tech’s investment. Amidst stringent regulations like the GDPR (General Data Protection Regulations) and other international laws, this AI-driven healthcare tech solution integrates an in-house cloud storage framework.
Unlike most AI solutions that store relevant information on external data storage systems, Shealth.AI religiously abides by GDPR’s data protection requirements by storing patients’ information safely on its proprietary cloud infrastructure. This ensures utmost compliance while providing organizations with absolute control of their data, all in total alignment with the dynamic healthcare tech data protection regulations.
Shealth.AI also unleashes the power of AI in clinical research, contributing further to the development of new treatments, medicines, disease prevention, and training courses.
“... Unwavering Dedication to Advancing AI Across Industries”
This partnership is a significant milestone as it marks XVC Tech's first entry into the healthcare space. Recently, the VC firm ventured into the blockchain development space through CodeRun.AI—an advanced solution that provides XDC network developers with comprehensive code generation and technical support. CodeRun.AI has become a household solution for XDC network developers seeking to build, deploy, and optimize smart contracts and decentralized applications (dApps) effectively.
With an unwavering dedication to advancing AI across industries and a firm commitment to supporting AI-driven solutions that prioritize privacy and compliance, XVC Tech has taken its first steps into the healthcare tech sector through its investment in Shealth.AI. Currently, the VC firm is actively searching for strategic partnerships with like-minded investors to expand and transform Shealth.AI’s innovative features into a global-scale solution. Speaking via a press release, Aneri Merchant, XVC Tech's Investment Manager, revealed that the VC firm is excited to support this revolutionary healthcare tech solution.
“XVC Tech is thrilled to support Shealth.AI’s mission to make healthcare more precise, efficient, and accessible while prioritizing data privacy. Our initial funding and technical guidance have helped Shealth.AI leverage AI to impact the healthcare industry meaningfully. With Shealth.AI’s GDPR-compliant infrastructure, hospitals and diagnostics companies can confidently integrate AI into their operations without compromising patient data security,” she said.
Founder and Chief Scientist at Shealth.AI also revealed via the aforementioned source how impactful XVC Tech's support has been to the project. “The support from XVC Tech has been invaluable. Our MVP is already making strides in diagnostic accuracy, and we’re just beginning. Together, we aim to revolutionize healthcare diagnostics, enhance patient experiences, and set a new standard for data privacy in healthcare through our advanced AI-driven solutions,” she added.
Conclusion
XVC Tech and Shealth.AI through this strategic investment hope to revolutionize the healthcare industry, harnessing AI’s potential to eliminate existing sticking points and transform the project into a global solution. Shealth.AI is actively seeking partnerships and investments from hospitals and institutions to facilitate, on a grander scale, the integration of its proprietary AI diagnostics solution into the healthcare sector. This aligns with its vision of collaboration and utilization of partnerships to transform into a worldwide healthcare tech provider.
XVC Tech, one of the leading venture capital (VC) firms committed to exploring potential investment opportunities in technology solutions, is entering the budding healthcare tech sector. Through a strategic investment into Shealth.AI—an Artificial Intelligence (AI) start-up dedicated to improving the healthcare sector—this is the VC firm’s first foray into the billion-dollar AI-based healthcare market.
Shealth.AI is leveraging AI to revolutionize global diagnostics, and since its launch, has become the go-to solution for labs, hospitals, and diagnostic centers. While the financial details of this investment are unknown, at least for now, it aims to harness Shealth.AI’s game-changing features to revamp the existing healthcare industry.
The current healthcare tech sector is problem-laden. The dearth of accurate clinical research, operating costs, regulatory issues, and privacy concerns are a few of the major sticking points in this industry. Shealth.AI and XVC, through this partnership, seek to eliminate them.
Eliminating Existing Industry Challenges
According to several studies and a disease incidence data report from 2012 to 2014, an estimated 594,000 patients die or are temporarily/ permanently disabled due to inaccurate diagnosis. Shealth.AI is positioned to eliminate this major problem. The leading healthcare tech solution leverages AI to guarantee quick yet nearly 99% accurate diagnostics in imaging-based assessments. This enhances clinical efficiency on a greater scale as well as improves patient care outcomes.
Shealth.AI’s dedication to privacy is another standout feature and a crucial driver behind XVC Tech’s investment. Amidst stringent regulations like the GDPR (General Data Protection Regulations) and other international laws, this AI-driven healthcare tech solution integrates an in-house cloud storage framework.
Unlike most AI solutions that store relevant information on external data storage systems, Shealth.AI religiously abides by GDPR’s data protection requirements by storing patients’ information safely on its proprietary cloud infrastructure. This ensures utmost compliance while providing organizations with absolute control of their data, all in total alignment with the dynamic healthcare tech data protection regulations.
Shealth.AI also unleashes the power of AI in clinical research, contributing further to the development of new treatments, medicines, disease prevention, and training courses.
“... Unwavering Dedication to Advancing AI Across Industries”
This partnership is a significant milestone as it marks XVC Tech's first entry into the healthcare space. Recently, the VC firm ventured into the blockchain development space through CodeRun.AI—an advanced solution that provides XDC network developers with comprehensive code generation and technical support. CodeRun.AI has become a household solution for XDC network developers seeking to build, deploy, and optimize smart contracts and decentralized applications (dApps) effectively.
With an unwavering dedication to advancing AI across industries and a firm commitment to supporting AI-driven solutions that prioritize privacy and compliance, XVC Tech has taken its first steps into the healthcare tech sector through its investment in Shealth.AI. Currently, the VC firm is actively searching for strategic partnerships with like-minded investors to expand and transform Shealth.AI’s innovative features into a global-scale solution. Speaking via a press release, Aneri Merchant, XVC Tech's Investment Manager, revealed that the VC firm is excited to support this revolutionary healthcare tech solution.
“XVC Tech is thrilled to support Shealth.AI’s mission to make healthcare more precise, efficient, and accessible while prioritizing data privacy. Our initial funding and technical guidance have helped Shealth.AI leverage AI to impact the healthcare industry meaningfully. With Shealth.AI’s GDPR-compliant infrastructure, hospitals and diagnostics companies can confidently integrate AI into their operations without compromising patient data security,” she said.
Founder and Chief Scientist at Shealth.AI also revealed via the aforementioned source how impactful XVC Tech's support has been to the project. “The support from XVC Tech has been invaluable. Our MVP is already making strides in diagnostic accuracy, and we’re just beginning. Together, we aim to revolutionize healthcare diagnostics, enhance patient experiences, and set a new standard for data privacy in healthcare through our advanced AI-driven solutions,” she added.
Conclusion
XVC Tech and Shealth.AI through this strategic investment hope to revolutionize the healthcare industry, harnessing AI’s potential to eliminate existing sticking points and transform the project into a global solution. Shealth.AI is actively seeking partnerships and investments from hospitals and institutions to facilitate, on a grander scale, the integration of its proprietary AI diagnostics solution into the healthcare sector. This aligns with its vision of collaboration and utilization of partnerships to transform into a worldwide healthcare tech provider.
X Open Hub brings High-Yield Liquidity Solutions to iFX EXPO Dubai
Hannah Hill on Innovation, Branding & Award-Winning Technology | Executive Interview | AXI
Hannah Hill on Innovation, Branding & Award-Winning Technology | Executive Interview | AXI
Recorded live at FMLS:25, this executive interview features Hannah Hill, Head of Brand and Sponsorship at AXI, in conversation with Finance Magnates, following AXI’s win for Most Innovative Broker of the Year 2025.
In this wide-ranging discussion, Hannah shares insights on:
🔹What winning the Finance Magnates award means for AXI’s credibility and innovation
🔹How the launch of AXI Select, the capital allocation program, is redefining industry standards
🔹The development and rollout of the AXI trading app across multiple markets
🔹Driving brand evolution alongside technological advancements
🔹Encouraging and recognizing teams behind the scenes
🔹The role of marketing, content, and social media in building product awareness
Hannah explains why standout products, strategic branding, and a focus on innovation are key to growing visibility and staying ahead in a competitive brokerage landscape.
🏆 Award Highlight: Most Innovative Broker of the Year 2025
👉 Subscribe to Finance Magnates for more executive interviews, industry insights, and exclusive coverage from the world’s leading financial events.
#FMLS25 #FinanceMagnates #MostInnovativeBroker #TradingTechnology #FinTech #Brokerage #ExecutiveInterview #AXI
Recorded live at FMLS:25, this executive interview features Hannah Hill, Head of Brand and Sponsorship at AXI, in conversation with Finance Magnates, following AXI’s win for Most Innovative Broker of the Year 2025.
In this wide-ranging discussion, Hannah shares insights on:
🔹What winning the Finance Magnates award means for AXI’s credibility and innovation
🔹How the launch of AXI Select, the capital allocation program, is redefining industry standards
🔹The development and rollout of the AXI trading app across multiple markets
🔹Driving brand evolution alongside technological advancements
🔹Encouraging and recognizing teams behind the scenes
🔹The role of marketing, content, and social media in building product awareness
Hannah explains why standout products, strategic branding, and a focus on innovation are key to growing visibility and staying ahead in a competitive brokerage landscape.
🏆 Award Highlight: Most Innovative Broker of the Year 2025
👉 Subscribe to Finance Magnates for more executive interviews, industry insights, and exclusive coverage from the world’s leading financial events.
#FMLS25 #FinanceMagnates #MostInnovativeBroker #TradingTechnology #FinTech #Brokerage #ExecutiveInterview #AXI
Executive Interview | Dor Eligula | Co-Founder & Chief Business Officer, BridgeWise | FMLS:25
Executive Interview | Dor Eligula | Co-Founder & Chief Business Officer, BridgeWise | FMLS:25
In this session, Jonathan Fine form Ultimate Group speaks with Dor Eligula from Bridgewise, a fast-growing AI-powered research and analytics firm supporting brokers and exchanges worldwide.
We start with Dor’s reaction to the Summit and then move to broker growth and the quick wins brokers often overlook. Dor shares where he sees “blue ocean” growth across Asian markets and how local client behaviour shapes demand.
We also discuss the rollout of AI across investment research. Dor gives real examples of how automation and human judgment meet at Bridgewise — including moments when analysts corrected AI output, and times when AI prevented an error.
We close with a practical question: how retail investors can actually use AI without falling into common traps.
In this session, Jonathan Fine form Ultimate Group speaks with Dor Eligula from Bridgewise, a fast-growing AI-powered research and analytics firm supporting brokers and exchanges worldwide.
We start with Dor’s reaction to the Summit and then move to broker growth and the quick wins brokers often overlook. Dor shares where he sees “blue ocean” growth across Asian markets and how local client behaviour shapes demand.
We also discuss the rollout of AI across investment research. Dor gives real examples of how automation and human judgment meet at Bridgewise — including moments when analysts corrected AI output, and times when AI prevented an error.
We close with a practical question: how retail investors can actually use AI without falling into common traps.
Brendan Callan joined us fresh off the Summit’s most anticipated debate: “Is Prop Trading Good for the Industry?” Brendan argued against the motion — and the audience voted him the winner.
In this interview, Brendan explains the reasoning behind his position. He walks through the message he believes many firms avoid: that the current prop trading model is too dependent on fees, too loose on risk, and too confusing for retail audiences.
We discuss why he thinks the model grew fast, why it may run into walls, and what he believes is needed for a cleaner, more responsible version of prop trading.
This is Brendan at his frankest — sharp, grounded, and very clear about what changes are overdue.
Brendan Callan joined us fresh off the Summit’s most anticipated debate: “Is Prop Trading Good for the Industry?” Brendan argued against the motion — and the audience voted him the winner.
In this interview, Brendan explains the reasoning behind his position. He walks through the message he believes many firms avoid: that the current prop trading model is too dependent on fees, too loose on risk, and too confusing for retail audiences.
We discuss why he thinks the model grew fast, why it may run into walls, and what he believes is needed for a cleaner, more responsible version of prop trading.
This is Brendan at his frankest — sharp, grounded, and very clear about what changes are overdue.
Elina Pedersen on Growth, Stability & Ultra-Low Latency | Executive Interview | Your Bourse
Elina Pedersen on Growth, Stability & Ultra-Low Latency | Executive Interview | Your Bourse
Recorded live at FMLS:25 London, this executive interview features Elina Pedersen, in conversation with Finance Magnates, following her company’s win for Best Connectivity 2025.
🔹In this wide-ranging discussion, Elina shares insights on:
🔹What winning a Finance Magnates award means for credibility and reputation
🔹How broker demand for stability and reliability is driving rapid growth
🔹The launch of a new trade server enabling flexible front-end integrations
🔹Why ultra-low latency must be proven with data, not buzzwords
🔹Common mistakes brokers make when scaling globally
🔹Educating the industry through a newly launched Dealers Academy
🔹Where AI fits into trading infrastructure and where it doesn’t
Elina explains why resilient back-end infrastructure, deep client partnerships, and disciplined focus are critical for brokers looking to scale sustainably in today’s competitive market.
🏆 Award Highlight: Best Connectivity 2025
👉 Subscribe to Finance Magnates for more executive interviews, industry insights, and exclusive coverage from the world’s leading financial events.
#FMLS25 #FinanceMagnates #BestConnectivity #TradingTechnology #UltraLowLatency #FinTech #Brokerage #ExecutiveInterview
Recorded live at FMLS:25 London, this executive interview features Elina Pedersen, in conversation with Finance Magnates, following her company’s win for Best Connectivity 2025.
🔹In this wide-ranging discussion, Elina shares insights on:
🔹What winning a Finance Magnates award means for credibility and reputation
🔹How broker demand for stability and reliability is driving rapid growth
🔹The launch of a new trade server enabling flexible front-end integrations
🔹Why ultra-low latency must be proven with data, not buzzwords
🔹Common mistakes brokers make when scaling globally
🔹Educating the industry through a newly launched Dealers Academy
🔹Where AI fits into trading infrastructure and where it doesn’t
Elina explains why resilient back-end infrastructure, deep client partnerships, and disciplined focus are critical for brokers looking to scale sustainably in today’s competitive market.
🏆 Award Highlight: Best Connectivity 2025
👉 Subscribe to Finance Magnates for more executive interviews, industry insights, and exclusive coverage from the world’s leading financial events.
#FMLS25 #FinanceMagnates #BestConnectivity #TradingTechnology #UltraLowLatency #FinTech #Brokerage #ExecutiveInterview
In this video, we take an in-depth look at @BlueberryMarketsForex , a forex and CFD broker operating since 2016, offering access to multiple trading platforms, over 1,000 instruments, and flexible account types for different trading styles.
We break down Blueberry’s regulatory structure, including its Australian Financial Services License (AFSL), as well as its authorisation and registrations in other jurisdictions. The review also covers supported platforms such as MetaTrader 4, MetaTrader 5, cTrader, TradingView, Blueberry.X, and web-based trading.
You’ll learn about available instruments across forex, commodities, indices, share CFDs, and crypto CFDs, along with leverage options, minimum and maximum trade sizes, and how Blueberry structures its Standard and Raw accounts.
We also explain spreads, commissions, swap rates, swap-free account availability, funding and withdrawal methods, processing times, and what traders can expect from customer support and additional services.
Watch the full review to see whether Blueberry’s trading setup aligns with your experience level, strategy, and risk tolerance.
📣 Stay up to date with the latest in finance and trading. Follow Finance Magnates for industry news, insights, and global event coverage.
Connect with us:
🔗 LinkedIn: /financemagnates
👍 Facebook: /financemagnates
📸 Instagram: https://www.instagram.com/financemagnates
🐦 X: https://x.com/financemagnates
🎥 TikTok: https://www.tiktok.com/tag/financemagnates
▶️ YouTube: /@financemagnates_official
#Blueberry #BlueberryMarkets #BrokerReview #ForexBroker #CFDTrading #OnlineTrading #FinanceMagnates #TradingPlatforms #MarketInsights
In this video, we take an in-depth look at @BlueberryMarketsForex , a forex and CFD broker operating since 2016, offering access to multiple trading platforms, over 1,000 instruments, and flexible account types for different trading styles.
We break down Blueberry’s regulatory structure, including its Australian Financial Services License (AFSL), as well as its authorisation and registrations in other jurisdictions. The review also covers supported platforms such as MetaTrader 4, MetaTrader 5, cTrader, TradingView, Blueberry.X, and web-based trading.
You’ll learn about available instruments across forex, commodities, indices, share CFDs, and crypto CFDs, along with leverage options, minimum and maximum trade sizes, and how Blueberry structures its Standard and Raw accounts.
We also explain spreads, commissions, swap rates, swap-free account availability, funding and withdrawal methods, processing times, and what traders can expect from customer support and additional services.
Watch the full review to see whether Blueberry’s trading setup aligns with your experience level, strategy, and risk tolerance.
📣 Stay up to date with the latest in finance and trading. Follow Finance Magnates for industry news, insights, and global event coverage.
Connect with us:
🔗 LinkedIn: /financemagnates
👍 Facebook: /financemagnates
📸 Instagram: https://www.instagram.com/financemagnates
🐦 X: https://x.com/financemagnates
🎥 TikTok: https://www.tiktok.com/tag/financemagnates
▶️ YouTube: /@financemagnates_official
#Blueberry #BlueberryMarkets #BrokerReview #ForexBroker #CFDTrading #OnlineTrading #FinanceMagnates #TradingPlatforms #MarketInsights
